Y Mabs Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $137k | 20k | 6.82 |
| 2023-09-30 | $110k | 20k | 5.45 |
| 2023-06-30 | $136k | 20k | 6.79 |
| 2023-03-31 | $101k | 20k | 5.01 |
| 2022-12-31 | $64k | 13k | 4.88 |
| 2022-09-30 | $298k | 21k | 14.42 |
| 2022-06-30 | $313k | 21k | 15.13 |
| 2022-03-31 | $246k | 21k | 11.88 |
| 2021-12-31 | $218k | 13k | 16.21 |
| 2021-09-30 | $383k | 13k | 28.54 |
| 2021-06-30 | $453k | 13k | 33.80 |
| 2021-03-31 | $406k | 13k | 30.24 |
| 2020-12-31 | $664k | 13k | 49.50 |
| 2020-09-30 | $515k | 13k | 38.39 |
| 2020-06-30 | $580k | 13k | 43.24 |
| 2020-03-31 | $263k | 10k | 26.11 |
| 2019-12-31 | $315k | 10k | 31.25 |
| 2019-09-30 | $262k | 10k | 26.02 |
| 2019-06-30 | $230k | 10k | 22.87 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors